| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.062 | 0.3 |